HomeShreis Scalene Therapeutics LLC

Shreis Scalene Therapeutics LLC

Shreis Scalene Therapeutics Compiles 510K Market Clearance Application for the SHYCOCAN® Device That Disables Coronaviruses

To enable uninterrupted marketability, SSTx is now compiling a 510K market clearance application for the US FDA, with regulatory support provided by EMERGO (by UL).